An interventional study of Intervention 1: Mobilization during hospitalization and Intervention 2: Mobilization the first 4 postoperative weeks in Postoperative Pain, Acute, Postoperative Pain, Chronic and Bariatric Surgery, sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-20.
Sponsored by Esbjerg Hospital - University Hospital of Southern Denmark · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 180 studies in Pain, Postoperative with a site in Denmark — 8 open to participants now, 9 under way, 2 of them phase 3. Pain, Postoperative · Denmark.
Among the 180 studies in Pain, Postoperative with a site in Denmark, this one is the 38th largest by planned enrollment of the 129 interventional ones that give a count, is one of 5 that started in 2024, is one of 36 with no phase, and was the 174th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →8 of the 180 studies in Pain, Postoperative with a site in Denmark are open now. Recruiting first, the newest first:
Anne Juul Wikkelsø · Sites in Denmark
Ages 18+ · Women only
Arash Afshari · Sites in Denmark
Ages 1–6
Aarhus University Hospital · Sites in Denmark
Ages 18+
Copenhagen University Hospital, Hvidovre · Sites in Denmark
Ages 18+
University of Aarhus · Sites in Denmark
Ages 18–100 · Healthy volunteers
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
180 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 7 · Phase 3 8 · Phase 4 78
First in 1999; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 112 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 72 across the 129 interventional studies, 102 across the 51 observational. Of the 152 that completed or were terminated, 4 (3%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 180 have an industry lead sponsor. The 10 most frequent:
Esbjerg Hospital - University Hospital of Southern Denmark is the lead sponsor of 51 studies on the registry; 16 are open to participants now.
Esbjerg Hospital - University Hospital of Southern Denmark has 3 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
3 of the studies in Pain, Postoperative with a site in Denmark that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05541276Phase 3Arash AfshariMELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children | 2027-03-01 |
| NCT06797973Anne Juul WikkelsøEfficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section | 2027-05-31 |
| NCT06222151Esbjerg Hospital - University Hospital of Southern DenmarkRecovering From Bariatric Surgery: the Effects of Early Initiated and Supervised Mobilization | 2027-06-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 180 studies in Pain, Postoperative with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim is to investigate the effect of early initiated and supervised mobilization continued after discharge as management of postoperative pain and recovery following obesity surgery, including patient experiences, pain coping, physical functionality and quality of life.
Study aims;
The PhD study consists of two sub-studies. Study 1: Effect of early mobilization as pain management in patients recovering from obesity surgery. The study is a single center randomized controlled trial (RCT). Participants will be randomized with an allocation ratio of 1:1.
Study 2: Patient experiences with early mobilization and postoperative pain after surgery - An interview study Patients participating in both interventions (group A), will be invited to participate in two individual semi structured interviews.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participates in intervention 1 and 2
Other: Intervention 1: Mobilization during hospitalization · Other: Intervention 2: Mobilization the first 4 postoperative weeks
Participates in intervention 1, control in intervention 2
Other: Intervention 1: Mobilization during hospitalization · Other: Intervention 2: Mobilization the first 4 postoperative weeks · Other: Control group
Participates in intervention 2, control in intervention 1
Other: Intervention 1: Mobilization during hospitalization · Other: Intervention 2: Mobilization the first 4 postoperative weeks · Other: Control group
Control in both intervention 1 and 2
Other: Control group
Surgical ICU Optimal Mobilization Score (SOMS) will be used to initiate early mobilization. SOMS consists of five levels of mobilization reaching from no activity to ambulation. Thirty minutes after PACU-arrival, the patient will be asked to do lower leg exercises. If this is possible, the patient will advance to the next level of mobilization. If not possible, level zero is recorded and the patient rests for another 30 minutes before attempting level one again. This continues until the patient succeeds with level four. Safety criteria for advancing to the next level of mobilization are based on criteria for mobilizing patients in the ICU. The intervention group will receive standard care with additional supervised mobilization while hospitalized. This mobilization consist of walking 1000 steps on postoperative day (POD) 0 and 500 steps on POD1 before discharge. Step counts are measured using pedometers.
Intervention 2 will start the first weekday after discharge and continue for 4 weeks. Four supervised physical activity sessions and 8 sessions using telerehabilitation. The activities are low-intensity exercises (walking and lightly strength training using resistance bands) with progressed intensity throughout the weeks. The exercises will be individually progressed to meet the participant's level of activity, as it is important the participants benefit as much as possible from the intervention. The participants will receive information about different possibilities for leisure activities, for motivation to continue physical activity after the first 4 weeks.
The control group receives standard care. Patients are mobilized to sit at the bedside before being transferred to the surgical ward. However, it is not used as prophylactic pain management nor is there a structured evidence based protocol with regard to mobilization. The control group will also be equipped with pedometers. They are encouraged to mobilize, and they receive a form in which they can write down mobilization for each hour. There is no planned supervised mobilization. As patients in the control group are assigned to standard care, they will not receive any supervised physical activity after discharge.
Abdominal pain
Abdominal pain measured using a visual analog scale (VAS) of 0-10. A higher score indicates a worse pain.
Time frame: 24 hours post surgery
Physical function
A 6 minute walk test measured in metres
Time frame: Baseline, 1 month postoperative and 6 months postoperative
Abdominal pain
Abdominal pain measured using a visual analog scale (VAS) of 0-10. A higher score indicates a worse pain.
Time frame: At baseline, during intervention 1, 1 month postoperative and 6 months postoperative
Morphine equivalent consumption
Measured in milligram intravenous
Time frame: At baseline, during intervention 1, at discharge (at the end of intervention 1), 1 month postoperative and 6 months postoperative
Patient reported pain experiences
APS-POQ-R-D questionnaire.
Time frame: At baseline, during intervention 1, 1 month postoperative and 6 months postoperative
Pain self-efficacy
PSEQ-DK questionnaire. Pain self-efficacy is measured on a score of 0-60. A higher score indicates a greater pain self-efficacy.
Time frame: At baseline, during intervention 1, 1 month postoperative and 6 months postoperative
Pain catastrophizing
Pain Catastrophizing Scale questionnaire. Pain Catastrophizing is measured on a score of 0-52. A higher score indicates a higher pain catastrophizing.
Time frame: At baseline, during intervention 1, 1 month postoperative and 6 months postoperative
Postoperative nausea and vomiting
On a visual analog scale (VAS) of 0-10. A higher score indicates worse nausea.
Time frame: During intervention 1, at discharge (at the end of intervention 1), 1 month postoperative and 6 months postoperative
Health related quality of life (SF-36)
Questionnaire SF-36. Health related quality of life is measured at a scale of 0-100. A higher score indicates a greater quality of life.
Time frame: At baseline, during intervention 1, 1 month postoperative and 6 months postoperative
Physical activity
Measured using accelerometers - minutes low/medium/high activity performed per hour. Measured for 7 days at baseline, 7 days 1 month postoperative and 7 days 7 months postoperative
Time frame: At baseline, 1 month postoperative and 6 months postoperative
Readmission
Readmissions during study period
Time frame: 1 month postoperative and 6 months postoperative
Plan to share: No
Started Apr 2024 (actual). Primary completion is estimated for Jun 2027, 37 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 37 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Esbjerg Hospital - University Hospital of Southern Denmark